BEST MEDICINES FOR OUR BEST FRIENDS
Our goal with this strategy is a 50 to 70% success rate, which greatly surpasses the norms in typical drug development of new chemical entities. We develop our therapeutics for an average of $5 million to $8 million in only 3 to 6 years. The market for veterinary drugs may only be one tenth the size of the human market, but the cost of development is about 1/100th. This makes our ROI very attractive and is consistent with our mission of delivering favorable returns for our shareholders, while at the same time improving and saving the lives of cats, dogs, and horses.
1. Pet industry market size & ownership statistics. American pet products association. Available from: http://www.americanpetproducts.org/press_industrytrends.asp [Access Date: September 16, 2019]